Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -6.02
- Piotroski Score 3.00
- Grade Neutral
- Symbol (RAPT)
- Company RAPT Therapeutics, Inc.
- Price $1.92
- Changes Percentage (-2.3%)
- Change -$0.05
- Day Low $1.91
- Day High $2.08
- Year High $27.35
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $48.00
- High Stock Price Target $55.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.08
- Trailing P/E Ratio -1.25
- Forward P/E Ratio -1.25
- P/E Growth -1.25
- Net Income $-116,798,000
Income Statement
Quarterly
Annual
Latest News of RAPT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Raptors rookie G Ja'Kobe Walter to miss training camp because of sprained right shoulder
Toronto Raptors rookie guard Ja'Kobe Walter will miss the team's training camp due to a shoulder injury. The 19th pick in the NBA Draft was injured during workouts and his condition will be updated af...
By AP NEWS | 2 days ago -
RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability
Insider Monkey published a list of worst 52-week low stocks, including RAPT Therapeutics, Inc. Amidst a 50 basis point interest rate cut by the Federal Reserve, the market is showing signs of recovery...
By Yahoo! Finance | 5 days ago -
Arijit Singh review - Indian superstar's four-hour marathon holds audience rapt
Arijit Singh, Bollywood's top male vocalist, showcases his vocal prowess at Co-Op Live in Manchester. With a mix of Bollywood hits and powerful performances, Singh captivates the audience with his ric...
By The Guardian | 1 week ago